Tae-Oh Kim
Overview
Explore the profile of Tae-Oh Kim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hong S, Baek D, Song G, Lee H, Lee S, Cha R, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075598
: The clinical characteristics of colorectal mucosa-associated lymphoid tissue (MALT) lymphoma remain poorly defined, and there is no standardized treatment for the disease. Therefore, we investigated the clinical characteristics of...
2.
Na J, Park Y, Park J, Kim T, Lee J, Park S, et al.
Medicine (Baltimore)
. 2024 Oct;
103(41):e40074.
PMID: 39465809
Predicting treatment response in Crohn's disease (CD) patients initiating biological therapy is crucial. The first step involves considering symptom control and normalization of C-reactive protein (CRP). However, data on the...
3.
Hyun H, Kim J, Lee J, Jeen Y, Kim T, Kim J, et al.
J Clin Gastroenterol
. 2024 Oct;
PMID: 39453701
Background: Thiopurines play an important role in the management of steroid-refractory and steroid-dependent ulcerative colitis. However, the effectiveness of the early use of thiopurines in ulcerative colitis remains controversial. Materials...
4.
Na J, Park Y, Park J, Kim T, Lee J, Lee J, et al.
J Pers Med
. 2024 Oct;
14(10).
PMID: 39452572
Background: Few studies have compared the efficacy and safety of second-line biological therapies in ulcerative colitis (UC) patients with prior exposure to anti-tumor necrosis factor (TNF) therapy. We aim to...
5.
Na J, Park Y, Park J, Kim T, Lee J, Park S, et al.
BMC Gastroenterol
. 2024 Sep;
24(1):306.
PMID: 39261766
Background: Numerous studies have compared the efficacy of ustekinumab (UST) and anti-TNF agents [infliximab (IFX) or adalimumab(ADA)] in moderate to severe Crohn's disease (CD) patients. This study aims to compare...
6.
Kim H, Na J, Kim S, Kim T, Park S, Lee C, et al.
Microorganisms
. 2024 Jan;
12(1).
PMID: 38257863
Recent research has demonstrated the potential of fecal microbiome analysis using machine learning (ML) in the diagnosis of inflammatory bowel disease (IBD), mainly Crohn's disease (CD) and ulcerative colitis (UC)....
7.
Na J, Jung S, Choi A, Kim S, Kim T
Mycoses
. 2024 Jan;
67(1):e13689.
PMID: 38214414
Background: Limited reports exist regarding invasive fungal diseases (IFDs) in inflammatory bowel disease (IBD) patients. Objectives: This study aims to investigate the incidence and risk factors of IFDs, specifically invasive...
8.
Na J, Kim B, Jung S, Choi A, Kim S, Kim T
Medicine (Baltimore)
. 2023 Oct;
102(43):e35514.
PMID: 37904446
Although the use of colorectal endoscopic submucosal dissection (ESD) for colorectal lesions has increased, there is a lack of analysis of the recent usage trends of ESD. Thus, this study...
9.
Park S, Lee G, Kim S, Lee C, Choi C, Kang S, et al.
Int J Mol Sci
. 2023 Oct;
24(19).
PMID: 37834250
We investigated whether the response to anti-tumor necrosis factor (anti-TNF) treatment varied according to inflammatory tissue characteristics in Crohn's disease (CD). Bulk RNA sequencing (RNA-seq) data were obtained from inflamed...
10.
Lee Y, Park S, Kim K, Kim T, Lee S
Toxins (Basel)
. 2023 Sep;
15(9).
PMID: 37755997
Fungal infection and mycotoxin contamination are major hazards to the safe storage and distribution of foods and feeds consumed by humans and livestock. This study investigated the antifungal and antiaflatoxigenic...